Delivery Order SPE2DB22D7065-SPE2DB24FH2QX

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ROTATEQ vaccine in 2 mL doses. The contract has a ceiling value of $2,887.24 and a completion date of March 12, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 ml vials. The contract has a total ceiling value of $1,009.64 and runs through August 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these critical vaccine supplies to support military treatment...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,885.60, is for the delivery of the ROTATEQ vaccine, a 2-milliliter dosage. The contract has an ultimate completion date of January 15, 2025. This contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 milliliter vials. The contract has a ceiling value of $2,803.20 and runs through June 13, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,124.22, is for the supply of the ROTATEQ vaccine in 2 mL quantities. The contract is a firm fixed-price delivery order, with a completion date of June 6, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 mL dosages. The contract has a firm fixed price of $10,510.60 and a completion date of January 29, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,547.00, is for the delivery of the ROTATEQ vaccine in 2 milliliter quantities. The contract has an ultimate completion date of March 24, 2025 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This $4,204.24 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ROTATEQ vaccine 2ML. The contract has a completion date of September 27, 2024. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,107,429 units of the ROTATEQ vaccine in 2 mL vials. The $2,613.32 contract has a completion date of November 16, 2022 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ROTATEQ vaccine, a rotavirus vaccine, with a ceiling value of $10,549.02. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
  • SPE2DB22D7065
    Indefinite Delivery Contract
  • SPE2DB22D7065-SPE2DB24FH2QX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,249.56 firm-fixed-price contract is for the supply of the ROTATEQ vaccine in 2 ml doses. The contract has an ultimate completion date of September 3, 2024 and does not have a set-aside designation. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 11/29/24, 9:02 AM